Michael Fitzpatrick Wempe

This inventor holds 14 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: University of Colorado, J-Pharma Co., Ltd., Eastman Chemical Company. Active years: 2012-2025.

USPTO Granted Patents = 14 (Patent Applications = 3)

% Patents Active = 57.1

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 12(Granted Patents)

Location History:

Kingsport, TN (US) (2012)
Aurora, CO (US) (2012 - 2024)

Company Filing History:

8 out of 1,447

University of Colorado

Eastman Chemical Company

University of Virginia Patent Foundation

patents

6. 1 out of 90

National Jewish Health

patents

7. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12458628 - Cancer therapeutic (2025-11-04),

2. 12043601 - N-substituted-1H-1,2,4-triazole-3-carboxamides, analogues thereof, and methods of treatment using same (2024-07-23),

3. 12025596 - 6-oxo-pipecolic acid quantitation by mass spectrometry (2024-07-02),

4. 11964985 - Anti-cancer compounds targeting Ral GTPases and methods of using the same (2024-04-23),

5. 11472812 - Anti-cancer compounds targeting Ral GTPases and methods of using the same (2022-10-18),

6. RE48557 - Anti-cancer compounds targeting Ral GTPases and methods of using the same (2021-05-17),

7. 10689392 - Anti-cancer compounds targeting ral GTPases and methods of using the same (2020-06-23),

8. 10676480 - Anti-cancer compounds targeting Ral GTPases and methods of using the same (2020-06-09),

9. 10202397 - Anti-cancer compounds targeting Ral GTPases and methods of using the same (2019-02-12),

10. 10172835 - Anticancer agent composition (2019-01-08),

11. 10005750 - Developing potent urate transporter inhibitors: compounds designed for their uricosuric action (2018-06-26),

12. 9353121 - Anti-cancer compounds targeting Ral GTPases and methods of using the same (2016-05-31),

13. 8263094 - Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids and preparation thereof (2012-09-11),

14. 8183398 - 5-hydroxy-2-methyl-4H-pyran-4-one esters as novel tyrosinase inhibitors (2012-05-22),

Title: Inventor Michael Fitzpatrick Wempe

Introduction: Michael Fitzpatrick Wempe is a renowned inventor based in Aurora, Colorado. He is known for his innovative contributions to various fields.

Latest Patents: Michael Fitzpatrick Wempe holds several patents in the areas of technology and engineering, showcasing his dedication to advancing these industries.

Career Highlights: Throughout his career, Michael Fitzpatrick Wempe has demonstrated a keen ability to develop groundbreaking solutions to complex problems. His work has significantly impacted the way we approach technological challenges.

Collaborations: Michael Fitzpatrick Wempe has collaborated with leading experts in the field, further enhancing his innovative projects and bringing his ideas to life through strategic partnerships.

Conclusion: In conclusion, Michael Fitzpatrick Wempe's passion for innovation and his commitment to pushing the boundaries of technology make him a standout inventor in the industry.